MK7123-034: A Phase II Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced/Metastatic Solid Tumors

February 19, 2019
https://clinicaltrials.gov/ct2/results?id=NCT01974440
Cancer - Prostate, Solid Tumors, Cancer - Colorectal, Cancer - Lung
Principal Investigator: Ding Wang, MD
Cancer, Prostate Cancer, Phase 2, Phase II, Solid Tumors, NSCL, Colorectal, Pembrolizumab, MK3475, Advanced, Metastatic
Open